Evaluating Pathway through Pain
The study shows that patients who completed the course made significant improvements with regard to their perceived health status, level of disability, mood, confidence managing pain, problems in life due to pain and level of pain. Around one-third of participants made reliable changes in their levels of disability, depression and anxiety.
The research also indicates that patients who completed Pathway through Pain achieved significant improvements in the following outcome measures, from pre-intervention to post-intervention:
- 14% Reduction of Disability (ODI)
- 20% Improvement in Quality of Life (EQ-VAS)
- 20% Improvement of Confidence in Managing Pain
- 24% Reduction of Problems in Daily Life
- 16% Reduction of Pain Level
- 23% Reduction in Depression (PHQ-9)
- 22% Reduction in Anxiety (GAD-7)
COST SAVING PER PATIENT
REDUCTION IN HEALTHCARE COSTS
DAILY PROBLEMS REDUCTION
QUALITY OF LIFE BOOST
The research also tracked the healthcare costs of chronic pain patients from in-patient, out-patient and A&E services. The data indicates that the group who completed Pathway through Pain had a large average healthcare cost reduction of £240 in the year after the intervention.
The research findings evaluating the clinical effectiveness and cost-savings of Pathway Through Pain were published in the British Journal of Pain in July 2019.